87 related articles for article (PubMed ID: 23176003)
41. Emerging promise of epigenetics and DNA methylation for the diagnosis and management of women's cancers.
Jones A; Lechner M; Fourkala EO; Kristeleit R; Widschwendter M
Epigenomics; 2010 Feb; 2(1):9-38. PubMed ID: 22122746
[TBL] [Abstract][Full Text] [Related]
42. Methylation of CpG island promoters in uveal melanoma.
Moulin AP; Clément G; Bosman FT; Zografos L; Benhattar J
Br J Ophthalmol; 2008 Feb; 92(2):281-5. PubMed ID: 18211945
[TBL] [Abstract][Full Text] [Related]
43. Epigenetic and circulating biomarkers: future analytes for liquid biopsies.
Razvi E
Epigenomics; 2013 Dec; 5(6):615-7. PubMed ID: 24283876
[No Abstract] [Full Text] [Related]
44. Epigenetic gene regulation: early environmental exposures.
Dolinoy DC
Pharmacogenomics; 2007 Jan; 8(1):5-10. PubMed ID: 17187501
[No Abstract] [Full Text] [Related]
45. Epigenetics in the Diagnosis and Therapy of Malignant Melanoma.
Santourlidis S; Schulz WA; Araúzo-Bravo MJ; Gerovska D; Ott P; Bendhack ML; Hassan M; Erichsen L
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163453
[TBL] [Abstract][Full Text] [Related]
46. DNA methylation plasticity contributes to the natural history of metastasis.
Vizoso M; Esteller M
Cell Cycle; 2015; 14(18):2863-4. PubMed ID: 26223807
[No Abstract] [Full Text] [Related]
47. Switching enhancer methylation in metastatic melanoma.
Pfeifer GP
Pigment Cell Melanoma Res; 2016 Sep; 29(5):491-3. PubMed ID: 27374259
[No Abstract] [Full Text] [Related]
48. Stability and change in epigenetic regulation of immune cells.
Scott-Browne J; Shih HY
Immunol Rev; 2022 Jan; 305(1):5-8. PubMed ID: 35034371
[No Abstract] [Full Text] [Related]
49. Genetic and epigenetic engines of diversity in pathogenic microbes.
Billmyre RB; Heitman J
PLoS Pathog; 2017 Sep; 13(9):e1006468. PubMed ID: 28910393
[No Abstract] [Full Text] [Related]
50. [Chinese guidelines on standardized pathological diagnosis of melanoma(2021 version)].
;
Zhonghua Bing Li Xue Za Zhi; 2021 Jun; 50(6):572-582. PubMed ID: 34044496
[TBL] [Abstract][Full Text] [Related]
51. Multiple metastases from cutaneous malignant melanoma patients may display heterogeneous genomic and epigenomic patterns.
Harbst K; Staaf J; Måsbäck A; Olsson H; Ingvar C; Vallon-Christersson J; Ringnér M; Borg A; Jönsson G
Melanoma Res; 2010 Oct; 20(5):381-91. PubMed ID: 20848731
[TBL] [Abstract][Full Text] [Related]
52. DNA methylation and hepatocellular carcinoma.
Zhu J
J Hepatobiliary Pancreat Surg; 2006; 13(4):265-73. PubMed ID: 16858536
[TBL] [Abstract][Full Text] [Related]
53. Epigenetic change in DNA structure may serve as marker for melanoma.
Oncology (Williston Park); 2012 Oct; 26(10):930. PubMed ID: 23176003
[No Abstract] [Full Text] [Related]
54. Epigenetic markers of prognosis in melanoma.
Sigalotti L; Fratta E; Parisi G; Coral S; Maio M
Methods Mol Biol; 2014; 1102():481-99. PubMed ID: 24258994
[TBL] [Abstract][Full Text] [Related]
55. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E
Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230
[TBL] [Abstract][Full Text] [Related]
56. Gene promoter methylation--a potential cancer marker.
Ze-Jun- L; Masato M
Adv Clin Path; 2002 Jan; 6(1):43-6. PubMed ID: 17582948
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
